FDA approves Lilly's oral weight loss drug Foundayo
The U.S. Food and Drug Administration approved Foundayo (orforglipron), Eli Lilly and Company's (NYSE: LLY) oral weight loss medication for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)